Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones
Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones
复制标题
DOI:
10.1016/j.jnutbio.2006.08.006
复制
发表时间:
2007-06-01
影响因子:
5.6
通讯作者:
Clinton, Steven K.
中科院分区:
文献类型:
--
作者:
Guo, Yanping;Wang, Shihua;Clinton, Steven K.
Angiogenesis is an essential process involved in the development and progression of prostate cancer. Vascular endothelial growth factor (VEGF) is hypothesized to be a critical regulator of angiogenesis during prostate carcinogenesis. We have reported that dietary soy products inhibit prostate tumor progression in animal models, in association with a reduction in tumor microvessel density. The goal of the present study is to investigate potential antiangiogenic mechanisms of genistein, the major soy isoflavone, using in vitro systems. Genistein (550 mu M) significantly inhibited the growth of human umbilical vein endothelial cells (HUVECs) in control media when stimulated by supplemental VEGF or when cultured in hypoxia-exposed PC-3 prostate adenocarcinoma, cell conditioned media. These in vitro studies suggest detectable inhibitory effects by 5-10 mu M genistein (P